Skip to main content
UnicoCell logo

UnicoCell — Investor Relations & Filings

Ticker · 6794 ISIN · TW0006794001 TW Professional, scientific and technical activities
Open in API
Filings indexed 34 across all filing types
Latest filing 2026-05-21 Governance Information
Country TW Taiwan
Listing TW 6794

About UnicoCell

https://www.unicocell.com

UnicoCell Biomed Co., Ltd. specializes in regenerative medicine, focusing on the research, development, and clinical application of stem cell technologies. The company’s operations are centered on three primary axes: the development of novel stem cell therapeutics, the production of stem cell-derived exosomes, and the provision of cell manufacturing and Contract Development and Manufacturing Organization (CDMO) services. Its lead candidate, ELIXCYTE, is an adipose-derived stem cell therapy undergoing Phase 3 clinical trials for indications such as knee osteoarthritis and chronic kidney disease. Additionally, the company maintains an allogeneic stem cell bank and provides autologous adipose-derived stem cell therapy services. Utilizing patented manufacturing processes and proprietary technology, UnicoCell offers integrated solutions from research to large-scale production to address unmet medical needs in the regenerative therapy sector.

Recent filings

Filing Released Lang Actions
功能性委員會成員
Governance Information Classification · 75% confidence The document is a public disclosure from the “公開資訊觀測站” listing the composition of a company committee (convener, members, required expertise, operations). This is not minutes of a shareholder vote or a meeting announcement, nor is it financial statements or an earnings release. It fits “Governance Information” as it details board/committee structure and governance practices (Code: CGR).
2026-05-21 Chinese
功能性委員會成員
Governance Information Classification · 80% confidence The document is a table from the public information observatory listing a company’s board composition: convener, members, independent directors count, total directors count, and financial expertise. There is no indication of a change event (no appointment or resignation) and it focuses on governance structure. This matches a Governance Information report (CGR).
2026-05-21 Chinese
公告本公司董事會委任薪資報酬委員會委員
Board/Management Information Classification · 85% confidence The document is a corporate disclosure on the public information observatory (公開資訊觀測站) announcing changes in the board-level remuneration committee membership. It lists former and new independent directors, effective dates, and reasons. This is an announcement of changes in the company’s board/management structure, matching the Board/Management Information category (MANG).
2026-05-20 Chinese
公告本公司審計委員會委員異動
Board/Management Information Classification · 90% confidence The document is an announcement of changes in the company’s Audit Committee members, listing outgoing and incoming independent directors and effective dates. This clearly falls under Board/Management Information, which covers announcements of changes in the board of directors or senior management.
2026-05-20 Chinese
公告本公司董事會選任董事長
Board/Management Information Classification · 85% confidence The document is a corporate announcement from a listed company (6794 向榮生技) disclosing the board of directors’ election of the chairman, including old and new officeholder details and effective date. This fits the category for Board/Management Information (MANG).
2026-05-20 Chinese
公告本公司115年股東常會通過解除董事競業禁止之限制
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an official announcement of the results of the company’s 2026 Annual General Meeting shareholder vote (approval to lift competition prohibition on directors), including vote counts and resolutions. This fits the category for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-20 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.